AbbVie Presents Investigational Navitoclax Preliminary Data in JAK Inhibitor Naïve Myelofibrosis Patients Pharmaceutical Investing
New Data Demonstrates AbbVie's VENCLYXTO®/VENCLEXTA® Combination Sustained Progression-Free Survival in Chronic Lymphocytic Leukemia Patients After Four Years Off Treatment Pharmaceutical Investing
The Gummy Project to Be Exclusive Supplier of Gummies for 2022 "Bard on the Beach Shakespeare Festival" in Vancouver Life Science Investing
Bristol Myers Squibb to Report Results for Second Quarter 2022 on July 27, 2022 Pharmaceutical Investing
Gummy Project Announces Completion of Initial Production Run of Watermelon Sharks and Peachy Bee Gummies Life Science Investing
AbbVie to Present Extensive Data from its Migraine Portfolio at the 2022 American Headache Society® Annual Scientific Meeting Pharmaceutical Investing
Awakn Life Sciences Appoints Biotech and Investment Veteran Dennis Purcell as a Special Advisor to the CEO Company News
Bristol Myers Squibb to Participate in Goldman Sachs 43rd Annual Global Healthcare Conference Pharmaceutical Investing
